Canine Parvovirus

Veterinary Clinics of North America - Small Animal Practice

Volumn 40, Issue 6, 2010, Pages 1041-1053

  Goddard, Amelia ^a   Leisewitz, Andrew L ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Canine; Hemorrhagic enteritis; Parvovirus; Vaccination

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTIEMETIC AGENT; BETA LACTAM ANTIBIOTIC; FELINE PANLEUKOPENIA VIRUS 2B VACCINE; FRESH FROZEN PLASMA; METOCLOPRAMIDE; METRONIDAZOLE; ONDANSETRON; OSELTAMIVIR; PENICILLIN DERIVATIVE; PROCHLORPERAZINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERFERON; RECOMBINANT OMEGA INTERFERON; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANEMIA; ANTIBODY TITER; CANINE PARVOVIRUS TYPE 1; CANINE PARVOVIRUS TYPE 2; CLINICAL FEATURE; DEHYDRATION; DIAGNOSTIC TEST; DOG DISEASE; DRUG EFFICACY; DRUG MECHANISM; ELECTROLYTE DISTURBANCE; ENTERIC FEEDING; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE TRANSFUSION; FELINE PANLEUKOPENIA VIRUS; FLUID THERAPY; HISTOPATHOLOGY; INFECTION PREVENTION; INFECTION SENSITIVITY; MOLECULAR EPIDEMIOLOGY; MYOCARDITIS; NONHUMAN; PARVOVIRUS; PARVOVIRUS INFECTION; PATHOGENESIS; PLASMA TRANSFUSION; POLYMERASE CHAIN REACTION; REVIEW; VACCINATION; VIRAL GASTROENTERITIS; VIRUS REPLICATION; VIRUS SHEDDING; VOMITING;

ANIMALS; ANIMALS, NEWBORN; ANTIVIRAL AGENTS; DOG DISEASES; DOGS; ENTERITIS; INCIDENCE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS, CANINE;

CANINE PARVOVIRUS; CANIS FAMILIARIS; PARVOVIRUS;

EID: 77957355418     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2010.07.007     Document Type: Review

References (81)

1. Pollock R.V. The parvoviruses. II. Canine parvovirus. Compend Contin Educ Pract Vet 1984, 6(7):653-664.
2. Smith-Carr S., Macintire D.K., Swango L.J. Canine parvovirus. Part I. Pathogenesis and vaccination. Compend Contin Educ Pract Vet 1997, 19(2):125-133.
3. Lamm C.G., Rezabek G.B. Parvovirus infection in domestic companion animals. Vet Clin North Am Small Anim Pract 2008, 38(4):837-850.
4. Pollock R.V. The parvoviruses. I. Feline panleukopenia virus and mink enteritis virus. Compend Contin Educ Pract Vet 1984, 6(3):227-241.
5. Binn L.N., Lazar E.C., Eddy G.A., et al. Recovery and characterization of a minute virus of canines. Infect Immun 1970, 1(5):503-508.
6. Pollock R.V., Coyne M.J. Canine parvovirus. Vet Clin North Am Small Anim Pract 1993, 23(3):555-568.
7. Parrish C.R., Have P., Foreyt W.J., et al. The global spread and replacement of canine parvovirus strains. J Gen Virol 1988, 69(5):1111-1116.
8. Buonavoglia C., Martella V., Pratelli A., et al. Evidence for evolution of canine parvovirus type 2 in Italy. J Gen Virol 2001, 82(12):3021-3025.
9. Nakamura M., Tohya Y., Miyazawa T., et al. A novel antigenic variant of canine parvovirus from a Vietnamese dog. Arch Virol 2004, 149(11):2261-2269.
10. Decaro N., Martella V., Desario C., et al. First detection of canine parvovirus type 2c in pups with haemorrhagic enteritis in Spain. J Vet Med B Infect Dis Vet Public Health 2006, 53(10):468-472.
11. Hong C., Decaro N., Desario C., et al. Occurrence of canine parvovirus type 2c in the United States. J Vet Diagn Invest 2007, 19(5):535-539.
12. Pérez R., Francia L., Romero V., et al. First detection of canine parvovirus type 2c in South America. Vet Microbiol 2007, 124(1):147-152.
13. Vieira M.J., Silva E., Oliveira J., et al. Canine parvovirus 2c infection in central Portugal. J Vet Diagn Invest 2008, 20(4):488-491.
14. Decaro N., Desario C., Addie D.D., et al. Molecular epidemiology of canine parvovirus, Europe. Emerg Infect Dis 2007, 13(8):1222-1224.
15. Hoskins J.D. Update on canine parvoviral enteritis. Vet Med 1997, 92(8):694-709.
16. Prittie J. Canine parvoviral enteritis: a review of diagnosis, management, and prevention. J Vet Emerg Crit Care 2004, 14(3):167-176.
17. Pollock R.V., Carmichael L.E. Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination. J Am Vet Med Assoc 1982, 180(1):37-42.
18. O'Brien S.E. Serologic response of pups to the low-passage, modified-live canine parvovirus-2 component in a combination vaccine. J Am Vet Med Assoc 1994, 204(8):1207-1209.
19. Brunner C.J., Swango L.J. Canine parvovirus infection: effects on the immune system and factors that predispose to severe disease. Compend Contin Educ Pract Vet 1985, 7(12):979-988.
20. Houston D.M., Ribble C.S., Head L.L. Risk factors associated with parvovirus enteritis in dogs: 283 cases (1982-1991). J Am Vet Med Assoc 1996, 208(4):542-546.
21. Glickman L.T., Domanski L.M., Patronek G.J., et al. Breed-related risk factors for canine parvovirus enteritis. J Am Vet Med Assoc 1985, 187(6):589-594.
22. Shakespeare A.S. The incidence of gastroenteritis diagnosis among sick dogs presented to the Onderstepoort Veterinary Academic Hospital correlated with meteorological data. J S Afr Vet Assoc 1999, 70(2):95-97.
23. Johnson R.H., Smith J.R. Epidemiology and pathogenesis of canine parvovirus. Aust Vet Pract 1983, 13(1):31.
24. Macartney L., McCandlish I.A.P., Thompson H., et al. Canine parvovirus enteritis. 2. Pathogenesis. Vet Rec 1984, 115(18):453-460.
25. Appel M., Meunier P., Pollock R., et al. Canine viral enteritis, a report to practitioners. Canine Pract 1980, 7(4):22-36.
26. Meunier P.C., Cooper B.J., Appel M.J., et al. Pathogenesis of canine parvovirus enteritis: sequential virus distribution and passive immunization studies. Vet Pathol 1985, 22(6):617-624.
27. Meunier P.C., Cooper B.J., Appel M.J., et al. Pathogenesis of canine parvovirus enteritis: the importance of viremia. Vet Pathol 1985, 22(1):60-71.
28. Jacobs R.M., Weiser M.G., Hall R.L., et al. Clinicopathologic features of canine parvoviral enteritis. J Am Anim Hosp Assoc 1980, 16(6):809-814.
29. O'Sullivan G., Durham P.J., Smith J.R., et al. Experimentally induced severe canine parvoviral enteritis. Aust Vet J 1984, 61(1):1-4.
30. Black J.W., Holscher M.A., Powell H.S., et al. Parvoviral enteritis and panleukopenia in dogs. Vet Med Small Anim Clin 1979, 74(1):47-50.
31. Otto C.M., Drobatz K.J., Soter C. Endotoxemia and tumor necrosis factor activity in dogs with naturally occurring parvoviral enteritis. J Vet Intern Med 1997, 11(2):65-70.
32. Macartney L., McCandlish I.A., Thompson H., et al. Canine parvovirus enteritis 1: clinical, haematological and pathological features of experimental infection. Vet Rec 1984, 115(9):201-210.
33. Robinson W.F., Huxtable C.R., Pass D.A., et al. Clinical and electrocardiographic findings in suspected viral myocarditis of pups. Aust Vet J 1979, 55(8):351-355.
34. Robinson W.F., Huxtable C.R., Pass D.A. Canine parvoviral myocarditis: a morphological description of the natural disease. Vet Pathol 1980, 17(3):282-293.
35. Turk J., Miller M., Brown T., et al. Coliform septicemia and pulmonary disease associated with canine parvoviral enteritis: 88 cases (1987-1988). J Am Vet Med Assoc 1990, 196(5):771-773.
36. Isogai E., Isogai H., Onuma M., et al. Escherichia coli associated endotoxemia in dogs with parvovirus infection. Jpn J Vet Sci 1989, 51(3):597-606.
37. Wessels B.C., Gaffin S.L. Anti-endotoxin immunotherapy for canine parvovirus endotoxaemia. J Small Anim Pract 1986, 27(10):609-615.
38. Weiss D.J., Rashid J. The sepsis-coagulant axis: a review. J Vet Intern Med 1998, 12(5):317-324.
39. Stander N., Wagner W.M., Goddard A., et al. Normal canine pediatric gastrointestinal ultrasonography. Vet Radiol Ultrasound 2010, 51(1):75-78.
40. Stander N., Wagner W.M., Goddard A., et al. Ultrasonographic appearance of canine parvoviral enteritis in puppies. Vet Radiol Ultrasound 2010, 51(1):69-74.
41. Goddard A., Leisewitz A.L., Christopher M.M., et al. Prognostic usefulness of blood leukocyte changes in canine parvoviral enteritis. J Vet Intern Med 2008, 22(2):309-316.
42. Potgieter L.N., Jones J.B., Patton C.S., et al. Experimental parvovirus infection in dogs. Can J Comp Med 1981, 45(3):212-216.
43. Boosinger T.R., Rebar A.H., DeNicola D.B., et al. Bone marrow alterations associated with canine parvoviral enteritis. Vet Pathol 1982, 19(5):558-561.
44. Cohn L.A., Rewerts J.M., McCaw D., et al. Plasma granulocyte colony-stimulating factor concentrations in neutropenic, parvoviral enteritis-infected puppies. J Vet Intern Med 1999, 13(6):581-586.
45. Panda D., Patra R.C., Nandi S., et al. Oxidative stress indices in gastroenteritis in dogs with canine parvoviral infection. Res Vet Sci 2009, 86(1):36-42.
46. Wilson J.J., Neame P.B., Kelton J.G. Infection-induced thrombocytopenia. Semin Thromb Hemost 1982, 8(3):217-233.
47. Axthelm M.K., Krakowka S. Canine distemper virus-induced thrombocytopenia. Am J Vet Res 1987, 48(8):1269-1275.
48. Otto C.M., Rieser T.M., Brooks M.B., et al. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000, 217(10):1500-1504.
49. Schoeman J.P., Goddard A., Herrtage M.E. Serum cortisol and thyroxine concentrations as predictors of death in critically ill puppies with parvoviral diarrhea. J Am Vet Med Assoc 2007, 231(10):1534-1539.
50. Schoeman J.P., Herrtage M.E. Serum thyrotropin, thyroxine and free thyroxine concentrations as predictors of mortality in critically ill puppies with parvovirus infection: a model for human paediatric critical illness?. Microbes Infect 2008, 10(2):203-207.
51. Macintire D.K., Smith-Carr S. Canine parvovirus. Part II. Clinical signs, diagnosis, and treatment. Compend Contin Educ Pract Vet 1997, 19(3):291-302.
52. Heald R.D., Jones B.D., Schmidt D.A. Blood gas and electrolyte concentrations in canine parvoviral enteritis. J Am Anim Hosp Assoc 1986, 22(6):745-748.
53. Mann F.A., Boon G.D., Wagner-Mann C., et al. Ionized and total magnesium concentrations in blood from dogs with naturally acquired parvoviral enteritis. J Am Vet Med Assoc 1998, 212(9):1398-1401.
54. Broek A.H. Serum protein electrophoresis in canine parvovirus enteritis. Br Vet J 1990, 146(3):255-259.
55. Mazzaferro E.M., Rudloff E., Kirby R. The role of albumin replacement in the critically ill veterinary patient. J Vet Emerg Crit Care 2002, 12(2):113-124.
56. Yilmaz Z., Senturk S. Characterisation of lipid profiles in dogs with parvoviral enteritis. J Small Anim Pract 2007, 48(11):643-650.
57. Rai A., Nauriyal D.C. A note on acid-base status and blood gas dynamics in canine parvo viral gastroenteritis. Indian J Vet Med 1992, 12(2):87-88.
58. Nappert G., Dunphy E., Ruben D., et al. Determination of serum organic acids in puppies with naturally acquired parvoviral enteritis. Can J Vet Res 2002, 66(1):15-18.
59. Pollock R.V., Carmichael L.E. Canine viral enteritis. Manual of small animal infectious diseases 1988, 101-107. Churchill Livingston, New York. J.E. Barlough (Ed.).
60. Helfer-Baker C., Evermann J.F., McKeirnan A.J., et al. Serological studies on the incidence of canine enteritis viruses. Canine Pract 1980, 7(3):37-42.
61. Mohan R., Nauriyal D.C., Singh K.B. Detection of canine parvo virus in faeces, using a parvo virus ELISA test kit. Indian Vet J 1993, 70(4):301-303.
62. Desario C., Decaro N., Campolo M., et al. Canine parvovirus infection: which diagnostic test for virus?. J Virol Methods 2005, 126(1):179-185.
63. JinSik O., GunWoo H., YoungShik C., et al. One-step immunochromatography assay kit for detecting antibodies to canine parvovirus. Clin Vaccine Immunol 2006, 13(4):520-524.
64. Brown A.J., Otto C.M. Fluid therapy in vomiting and diarrhea. Vet Clin North Am Small Anim Pract 2008, 38(3):653-675.
65. Lobetti R.G., Joubert K.E., Picard J., et al. Bacterial colonization of intravenous catheters in young dogs suspected to have parvoviral enteritis. J Am Vet Med Assoc 2002, 220(9):1321-1324.
66. Mohr A.J., Leisewitz A.L., Jacobson L.S., et al. Effect of early enteral nutrition on intestinal permeability, intestinal protein loss, and outcome in dogs with severe parvoviral enteritis. J Vet Intern Med 2003, 17(6):791-798.
67. Mantione N.L., Otto C.M. Characterization of the use of antiemetic agents in dogs with parvoviral enteritis treated at a veterinary teaching hospital: 77 cases (1997-2000). J Am Vet Med Assoc 2005, 227(11):1787-1793.
68. Rewerts J.M., McCaw D.L., Cohn L.A., et al. Recombinant human granulocyte colony-stimulating factor for treatment of puppies with neutropenia secondary to canine parvovirus infection. J Am Vet Med Assoc 1998, 213(7):991-992.
69. Mischke R., Barth T., Wohlsein P., et al. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on leukocyte count and survival rate of dogs with parvoviral enteritis. Res Vet Sci 2001, 70(3):221-225.
70. 21) for treatment of parvovirus enteritis: a randomized, double-blinded, placebo-controlled trial. J Vet Intern Med 2001, 15(4):355-360.
71. Ishiwata K., Minagawa T., Kajimoto T. Clinical effects of the recombinant feline interferon-ω on experimental parvovirus infection in Beagle dogs. J Vet Med Sci 1998, 60(8):911-917.
72. Martin V., Najbar W., Gueguen S., et al. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial. Vet Microbiol 2002, 89(2):115-127.
73. Mari K., Maynard L., Eun H.M., et al. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled field trial. Vet Rec 2003, 152(4):105-108.
74. Savigny M.R., Macintire D.K. Use of oseltamivir in the treatment of canine parvoviral enteritis. J Vet Emerg Crit Care 2010, 20(1):132-142.
75. Waner T., Naveh A., Wudovsky I., et al. Assessment of maternal antibody decay and response to canine parvovirus vaccination using a clinic-based enzyme-linked immunosorbent assay. J Vet Diagn Invest 1996, 8(4):427-432.
76. Buonavoglia C., Tollis M., Buonavoglia D., et al. Response of pups with maternal derived antibody to modified-live canine parvovirus vaccine. Comp Immunol Microbiol Infect Dis 1992, 15(4):281-283.
77. Bergman J.G., Muniz M., Sutton D., et al. Comparative trial of the canine parvovirus, canine distemper virus and canine adenovirus type 2 fractions of two commercially available modified live vaccines. Vet Rec 2006, 159(22):733-736.
78. Martella V., Cavalli A., Decaro N., et al. Immunogenicity of an intranasally administered modified live canine parvovirus type 2b vaccine in pups with maternally derived antibodies. Clin Diagn Lab Immunol 2005, 12(10):1243-1245.
79. Twark L., Dodds W.J. Clinical use of serum parvovirus and distemper virus antibody titers for determining revaccination strategies in healthy dogs. J Am Vet Med Assoc 2000, 217(7):1021-1024.
80. Kapil S., Cooper E., Lamm C., et al. Canine parvovirus types 2c and 2b circulating in North American dogs in 2006 and 2007. J Clin Microbiol 2007, 45(12):4044-4047.
81. Larson L.J., Schultz R.D. Do two current canine parvovirus type 2 and 2b vaccines provide protection against the new type 2c variant?. Vet Ther 2008, 9(2):94-101.